VRCA

Verrica Pharmaceuticals Inc. - Common Stock (VRCA)

About Verrica Pharmaceuticals Inc. - Common Stock (VRCA)

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$9.82
52 Week Low
$3.28
Market cap
76.4M
Dividend yield
-
Volume
400
Avg. volume
96,681
P/E ratio
-2.66

Verrica Pharmaceuticals Inc. - Common Stock News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$9.82
52 Week Low
$3.28
Market cap
76.4M
Dividend yield
-
Volume
400
Avg. volume
96,681
P/E ratio
-2.66